No Data
No Data
CHUGAI PHARMACEUTICAL CO To Go Ex-Dividend On December 27th, 2024 With 0.3608 USD Dividend Per Share
J.P. Morgan Maintains CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Raises Target Price to $56.46
Macquarie Maintains CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Cuts Target Price to $54.85
Morgan Stanley Initiates CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Announces Target Price $52.54
J.P. Morgan Initiates CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Announces Target Price $45.6
Jefferies Maintains CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Raises Target Price to $46.18